Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis
- 1 March 2000
- journal article
- Published by Elsevier in Human Immunology
- Vol. 61 (3) , 279-289
- https://doi.org/10.1016/s0198-8859(99)00135-4
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Expression of the human histocompatibility leukocyte antigen DR3 transgene reduces the severity of demyelination in a murine model of multiple sclerosis.Journal of Clinical Investigation, 1998
- Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous SystemCell, 1996
- Could HLA-DRB1 be the protective locus in rheumatoid arthritis?Immunology Today, 1995
- Immunological Aspects of Demyelinating DiseasesAnnual Review of Immunology, 1992
- The immunogenetic background of scleroderma-an overviewClinical and Experimental Dermatology, 1992
- HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosisHuman Immunology, 1991
- Analysis of HLA-DQ Genotypes and Susceptibility in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1990
- Patients with multiple sclerosis carry DQB1 genes which encode shared polymorphic amino acid sequencesHuman Immunology, 1989
- T cell tolerance by clonal elimination in the thymusCell, 1987
- Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity.The Journal of Experimental Medicine, 1983